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ABSTRACT
Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers are
synthetic sequence-selective DNA minor-groove
cross-linking agents that possess two electrophilic
imine moieties (or their equivalent) capable of
forming covalent aminal linkages with guanine
C2-NH2 functionalities. The PBD dimer SJG-136,
which has a C8–O–(CH2)3–O–C800 central linker
joining the two PBD moieties, is currently undergo-
ing phase II clinical trials and current research is
focused on developing analogues of SJG-136 with
different linker lengths and substitution patterns.
Using a reversed-phase ion pair HPLC/MS method
to evaluate interaction with oligonucleotides of
varying length and sequence, we recently reported
(JACS, 2009, 131, 13756) that SJG-136 can form
three different types of adducts: inter- and intra-
strand cross-linked adducts, and mono-alkylated
adducts. These studies have now been extended
to include PBD dimers with a longer central linker
(C8–O–(CH2)5–O–C80), demonstrating that the type
and distribution of adducts appear to depend on
(i) the length of the C8/C80-linker connecting the
two PBD units, (ii) the positioning of the two reactive
guanine bases on the same or opposite strands, and
(iii) their separation (i.e. the number of base pairs,
usually ATs, between them). Based on these data, a
set of rules are emerging that can be used to predict
the DNA–interaction behaviour of a PBD dimer of
particular C8–C80 linker length towards a given
DNA sequence. These observations suggest that it
may be possible to design PBD dimers to target
specific DNA sequences.
INTRODUCTION
Pyrrolobenzodiazepine (PBD) dimers [e.g. 1–3, Figure 1]
are synthetic sequence-selective DNA-interactive agents
based on the naturally occurring anthramycin family of
antitumour antibiotics (e.g. the PBD monomers anthr-
amycin and tomaymycin, Figure 1) that target the minor
groove of DNA (1–3). The PBD dimers contain two
C8-linked PBD monomer units, both of which contain
an electrophilic imine moiety at the N10-C11 position.
These imine moieties are known to bond covalently to
C2-NH2 functional groups of guanine bases in the DNA
minor groove thus providing the opportunity for DNA
cross-linking. Previous studies have shown that PBD
dimers with odd numbers of methylenes (e.g. n=3 or 5)
in the central C8–O–(CH2)n–O–C80 linker are the most
potent interstrand cross-linking agents (4,5). One
example with a C8–O–(CH2)3–O–C80 linker, 1 (SJG-136,
Figure 1), has shown clinical activity in early clinical trials
(6–8), and phase II studies in leukaemia and ovarian
cancer are currently underway.
We recently developed an ion pair reversed-phase high-
performance liquid chromatography/mass-spectrometry
(HPLC/MS) assay to evaluate the interaction of DNA-
binding agents with oligonucleotides of varying length
and sequence (9–12). Studies with 1 (SJG-136) showed
that the agent can form three types of adducts depending
on the DNA sequence and the space between reacting
guanine bases. In addition to the previously reported inter-
strand cross-linked adducts formed with Pu-GATC-Py
binding sites (i.e. Seq-1/Seq-1; Table 1) (13,14), it was
found that the agent could also form intrastrand
cross-links with Pu-GATG-Py sequences (i.e. Seq-2/
Seq-3; Table 1), although the interstrand adduct was pre-
dominant (see Figure 2 for graphical representation of
various adduct types) (12). However, insertion of an add-
itional base between the reactive guanines reversed this
preference, with intrastrand cross-links formed at Pu-G
AATG-Py sequences (Seq-6/Seq-7; Table 1) preferred
over the equivalent interstrand cross-links at Pu-GAAT
C-Py sequences (Seq-4/Seq-5; Table 1). Crucially, compe-
tition experiments showed that, given a choice between the
four sequences described above, 1 had a faster rate of
reaction with the extended intrastrand cross-linking
sequence Pu-GAATG-Py.
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can stabilize duplex DNA species through the formation
of covalent adducts (15). PBD dimers, which form inter-
or intrastrand cross-linked adducts, can stabilize DNA to
an even greater extent (13). For both PBD monomers and
dimers, this stabilizing property has been shown to correl-
ate well with their in vitro cytotoxicity (13,15). In particu-
lar, previous studies with SJG-136 (1) have shown that
intrastrand adduct formation can stabilize a 12-mer
duplex DNA oligonucleotide by up to 44 C, whereas
interstrand adduct formation can stabilize an isomeric
DNA sequence (differing only by having the guanines
on opposite strands) by up to 47 C (12).
The aim of the current study was to predict the binding
behaviour of PBD dimers towards a given DNA sequence
with a view to eventually designing novel PBD-based
agents that might produce predominantly one type of
DNA adduct in cells. For the HPLC/MS studies we
selected PBD dimers containing C8–O–(CH2)x–O–C80
linkers where X=3 (i.e. SJG-136, Figure 1) or 5 (i.e.
DRG-16, 2 (5), and ELB-21, 3 (16,17); Figure 1), and
DNA oligonucleotides with between one to four AT
base pairs between reacting guanines (Table 1). Two mol-
ecules containing a C8–O–(CH2)5–O–C80 linker were
studied because ELB-21 has additional methyl substitu-
ents at the C2/C20-positions, and so a comparison
between these two molecules could begin to address the
question of whether cross-linking preference is entirely a
function of C8/C80-linker length in the PBD family of
molecules, or whether other factors such as substitution
patterns play a role.
The results show that for PBD dimers with C8–O–
(CH2)3–O–C80 and C8–O–(CH2)5–O–C80 linkers, the
Figure 1. (A) Structures of the naturally occurring mono-alkylating PBD monomers anthramycin and tomaymycin, and the synthetic cross-linking
PBD dimers, SJG-136 (1), DRG-16 (2) and ELB-21 (3). (B) Diagram showing the mechanism of covalent interaction of an electrophilic PBD unit
with the nucleophilic C2-NH2 functional group of a guanine base resulting in formation of an aminal bond.
Table 1. Sequences of oligonucleotides used in the study
Label Sequence of
single-stranded
oligonucleotide
Label Sequence of
single-stranded
oligonucleotide
Seq-1 5′-TATAGATCTATA-3 Seq-8 5′-TATAGACTATA-3
Seq-9 5′-TATAGTCTATA-3
Seq-2 5′-TATAGATGTATA-3 Seq-10 5′-TATAGAGTATA-3
Seq-3 5′-TATACATCTATA-3 Seq-11 5′-TATACTCTATA-3
Seq-4 5′-TATAGAATCTATA-3 Seq-12 5′-TATAGAAATCTATA-3
Seq-5 5′-TATAGATTCTATA-3 Seq-13 5′-TATAGATTTCTATA-5
Seq-6 5′-TATAGAATGTATA-3 Seq-14 5′-TATAGAAATGTATA-3
Seq-7 5′-TATACATTCTATA-3 Seq-15 5′-TATACATTTCTATA-3
′
′
′
′
′
′
′
′
′
′
′
′
′
′
′
Complementary pairs of oligonucleotides are shown within boxes
(except for Seq-1 which is self-complementary).
Nucleic Acids Research, 2011,Vol.39, No. 13 5801type and distribution of adducts formed appear to depend
on (i) the positioning of the two reactive guanine bases on
the same or opposite strands, (ii) their separation (i.e. the
number of base pairs, in this case ATs, between them) and
(iii) the length of the C8/C80-linker connecting the two
PBD units. Although these results are presently limited
to three PBD dimers, a set of rules appears to be
emerging that has the potential to predict the binding be-
haviour of a PBD dimer of particular C8/C80-linker length
towards a given DNA sequence. For example, for the
interaction of a PBD dimer containing a C8–O–(CH2)3–
O–C80 linker (i.e. SJG-136) with binding sequences con-
taining two guanines on the same or opposite strands
separated by two A/T base pairs, there is a preference
for interstrand rather than intrastrand cross-link forma-
tion, whereas for shorter binding sequences (i.e. two
guanines separated by a single A/T base pair), interstrand
cross-linking is still preferred over intrastrand although
the rate of reaction is signiﬁcantly slower. For longer se-
quences (i.e. two guanines separated by three A/T base
pairs), compared to intrastrand cross-links are preferred
with a higher rate of formation compared to interstrand
cross-links. Crucially, similar rules appear to apply to
PBD dimers containing a C8–O–(CH2)5–O–C80 linker
(i.e. ELB-21 and DRG-16) but in relation to DNA se-
quences with two guanines separated by 2, 3 or 4 rather
than 1, 2 or 3 A/T base pairs. Molecular modelling can be
used to rationalize these observations, with the two extra
methylenes in the C8–C80 linker of DRG-16 (2) and
ELB-21 (3) equating to approximately one additional A/
T base pair in terms of length of the DNA helix. Although
SJG-136 (1) and DRG-16 (2) differ only in their C8–
C80-linker length and so can be directly compared in a
study of this type, the observation that ELB-21 (3),
which has modiﬁed C2/C20-substituents, behaves in an
almost identical manner to DRG-16, suggests that the
C8–C80 linker is the key determinant of sequence prefer-
ence as predicted by molecular modelling. However,
further studies on PBD dimers with different C-ring sub-
stituents will be required to conﬁrm this. It also remains to
be conﬁrmed that the DNA–interaction of PBD
monomers and dimers towards short oligonucleotides as
observed in studies such as this is predictive of their be-
haviour in cells where the DNA is compacted in the
genome and associated with histone proteins. However,
these results, and the simple rules that appear to explain
them, suggest that it may be possible to design PBD
dimers to target DNA sequences with reacting guanines
positioned on the same or opposite strands separated by a
predetermined number of A/T bases.
MATERIALS AND METHODS
HPLC/MS assay
Single-stranded oligonucleotides. The single-stranded (SS)
oligonucleotides were purchased from Eurogentec Ltd
(UK) and AtdBio Ltd (Southampton, UK) in a lyophilized
form.
Double-stranded oligonucleotides. Each oligonucleotide
was dissolved in 100mM ammonium acetate (Sigma–
Aldrich, UK) to form a stock solution of 2mM which
was later diluted to 1mM by addition of annealing buffer
(10mMTris/50mMsodium chloride/1mMethylenediami-
netetraacetic acid (EDTA)). Solutions of double-stranded
DNAs were prepared by heating the complementary SS
oligonucleotides (1mM) in annealing buffer (pH 8.5) to
70 C for 10min in a heating/cooling block (Grant Bio,
UK). The solutions were then allowed to cool slowly to
roomtemperature(RT)followedbystorageat 20 Cover-
night to ensure completion of the annealing process.
Working solutions of DNA duplexes of 50mM were
prepared by diluting the stored solutions with 20mM
ammonium acetate.
PBD dimers SJG-136 (1), DRG-16 (2) and ELB-21
(3). The PBD dimers 1, 2 and 3 were supplied by
Spirogen Ltd (Batch Numbers: SG2000.003, SG2057.002
and SG 2060.002, respectively) and were dissolved in 50/
50 v/v methanol/water to form stock solutions of 3mM
which were stored at  20 C for no longer than 4 months.
Working solutions of 200mM were prepared by diluting
the stock solutions with nuclease-free water. These were
stored at  20 C for not more than 1 week, and thawed to
RT for use when required.
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Figure 2. Representations of the various types of cross-linked adducts
formed between the different DNA sequences (see Table 1 for oligo-
nucleotides used) and the PBD dimers SJG-136 (1), DRG-16 (2) and
ELB-21 (3). The cross-linking base sequences are shown in red,
SJG-136 in blue, and DRG-16/ELB-21 in magenta.
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complexes were prepared by adding a PBD dimer
working solution to a duplex oligonucleotide solution in
a 4:1 molar ratio at room temperature. This incubation
mixture was then agitated for 5–10s using a vortex mixer.
Ion-pair reversed-phase HPLC. Analysis was performed
on a Thermo Electron HPLC system equipped with a
4.6 50mm Xterra MS C18 column packed with 2.5mM
particles (Waters Ltd, UK), an UV 1000 detector, an
AS3000 autosampler, an SCM1000 vacuum degasser and
Chromquest software (Version 4.1). A gradient system of
150mM triethyl ammonium bicarbonate (TEAB) as
buffer A and 40% acetonitrile in water (HPLC grade,
Fischer Scientiﬁc, UK) as buffer B was used. For buffer
A, a 1M pre-formulated solution of TEAB was purchased
from Sigma-Aldrich (UK) and diluted to the required con-
centration with HPLC grade water (Fischer Scientiﬁc,
UK). The gradient was ramped from 90% A at 0min to
50% at 20min, then 35% at 30min and ﬁnally to 10% at
45min. Ultraviolet (UV) absorbance was monitored at
254nm, and fractions containing separated components
were collected manually, combined when appropriate,
lyophilized and then analysed using either electron impact
mass spectrometry (EIMS) or matrix-assisted laser
desorption/ionization time of ﬂight (MALDI–TOF)-MS.
Lyophilization of HPLC fractions. Single or combined
HPLC fractions were lyophilized using two different
methods depending on the ﬁnal volume. For smaller
volumes (<0.5ml), lyophilizations were carried out in a
SpeedVac (Thermo Electron) using a temperature-free
4-h program. For larger volumes, the solvent was initially
frozen in a glass vial using liquid nitrogen, and then freeze
dried (Heto Lyolab 3000) for 2h.
Mass spectrometric analysis
MALDI-TOF. An Applied Biosystems Voyager DE-Pro
Biospectrometry Workstation MALDI–TOF mass spec-
trometer (Framingham, MA, USA) was used to obtain
MALDI–TOF spectra of components within lyophilized
fractions. Samples from fractions containing single com-
ponents were prepared by diluting with matrix (37mg
THAP in 1ml ACN, 45mg ammonium citrate in 1ml
water—mixed 1:1) either 2:1, 1:1 or 1:5 (sample:matrix)
prior to MALDI-TOF analysis. One microlitre of
sample was spotted onto the MALDI target plate and
allowed to dry. Samples were then analysed in positive
linear mode using delayed extraction (500ns) and an ac-
celerating voltage of 25000V. Acquisition was between
4000 and 15000Da with 100 shots/spectrum.
Molecular modelling
In order to examine the structural feasibility of the various
cross-linked DNA adducts, molecular models were con-
structed. To test the integrity of the structures under en-
ergetic conditions, dynamics simulations were carried out
at room temperature (300K). Minimized structures of
SJG-136 (1), DRG-16 (2) and ELB-21 (3) were con-
structed with ChemBioOfﬁce
TM (Cambridgesoft)
and exported in PDB format. Missing residue and chain
records were added, and atom names were made unique.
The AMBER package (18) was used for subsequent con-
version to the ‘mol2’ format applying Gasteiger charges
(antechamber), with missing parameters added through
the ‘parmchk’ routine. The DNA duplexes were made
with AMBER, and the adducts constructed manually in
the ﬁrst instance using ‘Xleap’ while maintaining the
S-conﬁguration at the C11 point of covalent attachment
of individual PBD units. Structures were then exported for
minimization, initially restraining the DNA atoms with a
high force constant to allow the bound ligand to ﬁnd an
optimal conformation within the minor groove without
distorting the overall DNA structure. Subsequent mini-
mization steps were applied while reducing the level of
restraint on the DNA atoms to zero in a stepwise
manner. The generalized Born/surface area (GB/SA)
implicit solvent model was used with monovalent electro-
static ion screening simulated with the SALTCON param-
eter set to 0.2 (M), and with a long-range non-bonded
cut-off employed.
Subsequent dynamics simulations over 2ns were then
performed under similar solvent conditions. With applica-
tion of the SHAKE algorithm to C–H bond vibrations, a
time step of 2fs was used. Individual energy terms were
saved every 200 steps (every 0.4ps), and the recorded
energies were used to plot graphs of the total potential
energy (PE) of the constructs against the simulation
time. The average PE for the whole simulation was also
recorded. Conformational variation in the course of the
dynamics simulations was examined by performing a rigid
body root mean square (RMS) ﬁt for the atoms of each
frame of the simulation to the ﬁrst frame and plotting this
parameter against simulation time.
RESULTS AND DISCUSSION
HPLC/MS studies
The study utilized previously reported HPLC/MS analyt-
ical methodology (9–12) and the 15 oligonucleotides listed
in Table 1. The oligonucleotide duplexes were designed to
have reactive guanines at appropriate positions on the
same or opposite strands to allow intrastrand or
interstrand cross-links to form but with varying numbers
of base pairs (i.e. 1-4 A/T base pairs) between the guanines
to evaluate the effect of inter-guanine distance. Incubation
of the PBDs with these annealed oligonucleotide duplexes
for speciﬁc time periods followed by injection of the
reaction mixture onto the HPLC column provided
distinct PBD/DNA adduct peaks that could be collected,
lyophilized and subjected to MALDI-TOF-MS analysis to
conﬁrm identity. Unreacted SS oligonucleotides and
annealed duplexes were also analysed in the same HPLC
system to provide reference peaks. As with previously
reported studies, a 4:1 molar ratio of ligand:oligonucleo-
tide was used, as it ensured completion of cross-link for-
mation within a reasonable time frame.
Cross-linked and monoalkylated adducts were char-
acterized based on both HPLC retention times and
MALDI–TOF data as previously reported for SJG-136
Nucleic Acids Research, 2011,Vol.39, No. 13 5803(12). In this original study, interstrand, intrastrand and
monoalkylated adducts were demonstrated to appear at
distinct retention times with this particular HPLC
system, and each was identiﬁed and characterized
through a series of guanine replacement studies and
MALDI–TOF MS data. The former involved replacement
of key guanines in various oligonucleotide duplexes with
inosine residues which lack the nucleophilic C2-NH2 func-
tionality of normal guanines. This allowed individual
adduct peaks at particular retention times to be positively
identiﬁed through a process of successive ‘knock-out’.
Following on from the previously reported study with 1
(SJG-136) and the Pu-GATC-Py, Pu-GATG-Py, Pu-GAA
TC-Py and Pu-GAATG-Py sequences (Supplementary
Figures S1–S14) (12), the ﬁrst experiment focused on the
shortened interstrand 50-Pu-GAC-Py (Seq-8/Seq-9 duplex;
Table 1) and intrastrand 50-Pu-GAG-Py sequences
(Seq-10/Seq-11 duplex; Table 1). Surprisingly, given the
difference in length between the molecule and reacting
guanines, the HPLC experiments showed that 1 is
capable of reacting with both sequences (Figure 3),
although it reacted faster with 50-Pu-GAC-Py indicating
that it prefers interstrand cross-link formation for these
shorter binding sequences. The reaction with 50-Pu-GAC-
Py was nearly complete within 6h (Figure 3C), whereas
reaction with the intrastrand 50-Pu-GAG-Py sequence was
still not complete after 24h (Figure 3D). Interestingly no
duplex adduct was observed in the HPLC assay after
reaction with the Pu-GAG-Py duplex (Figure 3D), with
the single stranded 1/Seq-10 adduct (RT=34min) being
the predominant product. This relative instability of the
duplex adduct under the HPLC conditions is consistent
with a higher level of structural distortion compared to
adducts formed from sequences with more A/T base
pairs between the guanines which presumably leads to a
greater rate of dissociation of the two DNA strands. A
control experiment demonstrated that 1 does not react
with Seq-10 (Pu-GAG-Py) alone, conﬁrming that the
observed 1/Seq-10 adduct must have resulted from dissoci-
ation of the initially formed duplex adduct. Although the
rate of adduct formation with 50-Pu-GAC-Py was much
faster than for 50-Pu-GAG-Py, it was signiﬁcantly slower
than for 50-Pu-GATC-Py. The identiﬁcation of all adduct
peaks was conﬁrmed using MALDI-TOF MS
(Supplementary Table S1).
Next, DRG-16 (2, C8–O–(CH2)5–O–C80) was studied
with the 50-Pu-GAATC-Py duplex (Seq-4/Seq-5, Table 1)
containing an additional A/T base pair between reacting
guanines compared to the 50-Pu-GATC-Py SJG-136 inter-
strand cross-linking sequence (Figure 4). For DRG-16,
this was previously suggested to be the ideal separation
between reactive guanines for an interstrand cross-link
based on molecular modelling studies (19). Analysis of
the annealed duplex formed from Seq-4 and Seq-5
resulted in two peaks at RT 27.0 and 27.3min identiﬁed
by MALDI–TOF MS as denatured SS Seq-4 and Seq-5,
respectively (Figure 4A). Mixing the annealed duplex with
2 followed by immediate analysis showed the partial
( 85%) formation of an adduct peak at RT 29.8min as
the major product (Figure 4B). A time course study
showed that interstrand adduct formation was almost
complete ( 95%) within 1h (Figure 4C). Intrastrand
cross-linking with the same separation between reacting
guanines was then investigated using the Seq-6/Seq-7
A
C
B
D
Figure 3. HPLC chromatograms; (A) Annealed Pu-GAC-Py duplex (Seq-8/Seq-9); (B) Annealed Pu-GAG-Py duplex (Seq-10/Seq-11); (C) 6 hours
after incubation of SJG-136 (1) with the Seq-8/Seq-9 duplex showing appearance of the 1/(Seq-8/Seq-9) interstrand cross-linked adduct at RT
31.3min and a small amount of 1/(Seq-8) monoalkylated adduct at RT 34.9min (resulting from partial denaturation of 1/(Seq-8/Seq-9), (D)2 4 h
after incubation of SJG-136 (1) with the Seq10/Seq-11 duplex showing appearance of the 1/Seq-10 monoalkylated adduct at RT 34.0min resulting
from complete denaturation of the initially formed 1/(Seq-10/Seq-11).
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TATA-30) had been mutated to a guanine (50-TATAGAA
TGTATA-30) (Table 1). Analysis of the annealed duplex
alone using identical HPLC conditions resulted in two
peaks at RT 27.1 and 28.2min, conﬁrmed by MALDI–
TOF MS to be the SS Seq-6 and Seq-7, respectively
(Figure 4D). Addition of 2 to the annealed Seq-6/Seq-7
duplex followed by immediate HPLC analysis showed the
rapid emergence of a peak at RT 29.8min, the identity of
which was conﬁrmed by MALDI–TOF MS as the intra-
strand 1:1 2/(Seq-6/Seq7) duplex adduct (Figure 4E). A
time course study showed the emergence of a minor
peak at RT 33.3min (see below), although the main
29.8min peak remained prominent with time and ac-
counted for more than 90% of the products at the end
of the experiment. The rate of intrastrand adduct forma-
tion with Seq-6/Seq7 was surprisingly rapid and complete
within 1h, with the peak corresponding to Seq-6 com-
pletely disappearing (Figure 4F). In the 0h (i.e.  5min)
chromatogram (Figure 4E), the ratio of peaks relating to
the unreacted SS DNA species (approximately equal in
Figure 4D before the addition of 2) had changed in
favour of Seq-7 (28.2min), suggesting that 2 had reacted
preferentially with Seq-6. However, the smaller peak at
33.3min had a m/z of 4609 consistent with the 1:1
2/Seq-6 monoalkylated adduct, indicating that a propor-
tion of the 1:1 2/(Seq-6/Seq7) adduct, once formed, had
dissociated on the HPLC column to the 1:1 2/Seq-6
monoalkylated adduct and Seq-7, thus explaining the pre-
dominance of the latter.
Similar HPLC experiments were conducted on the inter-
action of 2 with the self-complementary Pu-GATC-Py
duplex (Seq1/Seq1), originally reported as the preferred
binding site for 1 (13), and the corresponding intrastrand
Pu-GATG-Py duplex (Seq-2/Seq-3) (Figure 5). It was
observed that 2 reacted faster with the interstrand Pu-
GATC-Py sequence (Figure 5A–C) compared to the Pu-
GATG-Py intrastrand sequence (Figure 5D–F). Reaction
with Seq-2/Seq-3 was complete within 3h (Figure 5C),
whereas reaction with Seq-2/Seq-3 was incomplete even
after 24h (Figure 5F). In the case of reaction with
Pu-GATG-Py, two additional peaks were observed at
RT 33.5 and 36.3min. The ﬁrst was identiﬁed from MS
and retention time as the cross-linked SS 2/Seq-2 arising
from denaturation of the duplex intrastrand cross-linked
adduct 2/(Seq-2/Seq-3), and also explaining the excess of
A
B
C
D
E
F
Figure 4. HPLC chromatograms; (A) Annealed Pu-GAATC-Py duplex (Seq-4/Seq-5); (B) Immediately (i.e.  5min) after mixing DRG-16 (2) with
the Seq-4/Seq-5 duplex showing appearance of the 2/(Seq-4/Seq-5) interstrand adduct at RT 29.8min; (C) 1h after mixing 2 with the Seq-4/Seq-5
duplex followed by incubation at room temperature showing completion of reaction; (D) Annealed Pu-GAATG-Py duplex (Seq-6/Seq-7); (E)
Immediately ( 5min) after mixing DRG-16 (2) with the Seq-6/Seq-7 duplex showing appearance of the intrastrand 2/(Seq-6/Seq-7) duplex
adduct at RT 29.8min and a small amount of monoalkylated adduct at RT 33.3min; (F) 1h after mixing 2 with the Seq-6/Seq-7 duplex
showing the reaction nearing completion.
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at 36.3min was tentatively identiﬁed by similar means
based on previously reported inosine experiments (12) as
monoalkylated 2/Seq-2. It is noteworthy that the rates of
reactions for the interstrand cross-linking duplexes Pu-
GATC-Py and Pu-GAATC-Py were comparable but the
reaction rate was signiﬁcantly slower for the intrastrand
cross-linking Pu-GATG-Py duplex compared to the
longer Pu-GAATG-Py. This result clearly shows that 2
prefers interstrand cross-link formation with both the
Pu-GATC-Py and Pu-GAATC-Py sequences compared
to the equivalent intrastrand cross-linking sequences.
The identiﬁcation of all peaks was conﬁrmed from
MALDI–TOF–MS data (see Supplementary Data,
Supplementary Table S2).
To investigate the effect of inserting an additional base
between reactive guanines, two duplex oligonucleotides,
Seq-12/Seq-13 and Seq-14/Seq-15, were designed to
contain the extended interstrand (Pu-GAAATC-Py) and
intrastrand (Pu-GAAATG-Py) cross-linking sites, respect-
ively. After incubation of 2 with the Seq-12/Seq-13 duplex,
subsequent HPLC analysis showed the emergence of a
minor peak at RT 29.8mins and major peaks at RT
32.1 and 33.2min (Figure 6B). MALDI–TOF–MS data
conﬁrmed the minor 29.8min peak to be the interstrand
2/(Seq-12/Seq-13) adduct peak, whereas the RT 32.1 and
33.2min peaks were identiﬁed as closely eluting 1:1
2/Seq-12 and 1:1 2/Seq-13 monoalkylated adducts, re-
spectively (see Table 2 for MS data). A time course
study showed that adduct formation was still not complete
after 24h, with the 29.8min peak (i.e. the interstrand
cross-linked adduct) remaining as the minor peak through-
out the experiment (Figure 6C). These results indicate that
2 has a poor reactivity towards this extended interstrand
cross-linking site and forms a high proportion of mono-
alkylated adducts instead, presumably due to the two
PBD imine moieties failing to stretch effectively between
the two nucleophilic guanine sites. However, interaction of
2 with the extended intrastrand cross-linking sequence
Pu-GAAATG-Py (Seq-14/Seq-15) resulted in the rapid
(i.e.,  5mins) emergence of a major new peak at RT
29.8min along with two minor peaks at RT 32.7 and
33.9min (Figure 6E). As anticipated, the RT 29.8min
peak was identiﬁed from retention time and MALDI–
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Figure 5. HPLC chromatograms; (A)5 0-Pu-GATC-Py-30 (Seq-1/Seq-1) duplex denatured under HPLC conditions, RT 24.4min. (B) 1h after mixing
DRG-16 (2) with the Seq-1/Seq-1 duplex showing the appearance of an interstrand 2/(Seq-1/Seq-1) Pu-GATC-Py duplex adduct at RT 30.2min.
(C) 3h after mixing 2 with Seq-1/Seq-1 showing completion of reaction. (D) Pu-GATG-Py (Seq-2/Seq-3) duplex denatured under HPLC conditions.
(E) 1h after mixing 2 with the Seq-2/Seq-3 duplex showing the appearance of intrastrand 2/(Seq-2/Seq-3) Pu-GATG-Py duplex adduct at RT
30.1min. Two additional peaks were observed at RT 33.5 and 36.3min. (F) 24h after mixing 2 with Seq-2/Seq-3 showing that reaction was still not
complete.
5806 Nucleic Acids Research, 2011,Vol.39, No. 13TOF–MS data as the intrastrand 1:1 2/(Seq-14/Seq-15)
duplex adduct. The minor RT 32.7 and RT 33.9min
peaks gave MS data corresponding to single-stranded
1:1 2/Seq-14 adducts. Based on retention times from
previous studies with inosine-containing oligonucleotides
(12), the 32.7min peak was assigned as the 1:1 intrastrand
cross-linked 2/Seq-14 adduct, and the 33.9min peak as the
1:1 2/Seq-14 monoalkylated adduct. However, the
intrastrand cross-linked 1:1 2/(Seq-14/Seq-15) duplex
adduct was clearly the most abundant species. Crucially,
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with the Seq-12/Seq-13 duplex showing appearance of a minor interstrand Pu-GAAATC-Py duplex adduct at RT 29.8min, along with
single-stranded 2/(Seq-12) and 2/(Seq-13) adducts at RT 32.1 and 33.2min, respectively. (C) Negligible change after 24h except for a small
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Table 2. Theoretical and observed masses of the double-stranded oligonucleotides and their 1:1 adducts with SJG-136 (1), DRG-16 (2) and
ELB-21 (3)
DNA sequence of duplex
oligonucleotide
Theoretical
mass of DNA
duplex alone
Observed (1:1)
DNA/SJG-136
adduct mass
(DNA mass+556.61)
Observed (1:1)
DNA/DRG-16
adduct mass
(DNA mass+584.66)
Observed (1:1)
DNA/ELB-21
adduct mass
(DNA mass+612.72)
Pu-GATC-Py (Seq-1/Seq-1) 7287.4 7841.3 7871.2 7902.45
Pu-GATG-Py (Seq-2/Seq-3) 7286.74 7842.06 7873.2 7903.0
Pu-GAATC-Py (Seq-4/Seq-5) 7904.13 8458.3 8485.6 8517.8
Pu-GAATG-Py (Seq-6/Seq-7) 7904.13 8459.1 8488.7 8516.0
Pu-GAC-Py (Seq-13/Seq-14) 6669.17 7225.78 N/A N/A
Pu-GAG-Py (Seq-10/Seq-11) 6669.17 7225.61 N/A N/A
Pu-GAAATC-Py (Seq-12/Seq-13) 8522.05 N/A 9108.2 9136.3
Pu-GAAATG-Py (Seq-14/Seq-15) 8522.05 N/A 9107.3 9136.4
N/A - Not available, as the sequence is either too short or too long to form cross-links with respective agents.
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was complete within 1h (Figure 6F), whereas reaction
with the interstrand Pu-GAAATC-Py duplex had pro-
ceeded to only a small extent after 24h (Figure 6C). It is
noteworthy that the rate of reaction for the interstrand
cross-linking duplex Pu-GAAATC-Py was signiﬁcantly
slower than for the shorter Pu-GATC-Py duplex but the
rate of intrastrand cross-linking with the Pu-GAAATG-
Py duplex duplex was faster compared to Pu-GATG-Py.
Together, these data clearly demonstrate the preference of
2 to form intrastrand cross-links with an extended DNA
sequence (i.e. four AT base pairs between reacting
guanines), thus mirroring the behaviour of the shorter
SJG-136 (1) molecule towards sequences containing
three AT base pairs between reacting guanines. This
result is consistent with the molecular modelling studies
(see below) which suggest that the length of the extra two
methylenes of the C8–O–(CH2)5–O–C80 central linker of 2
compared to the C8–O–(CH2)3–O–C80 linker of 1 equate
to approximately one base pair spacing within the DNA
minor groove.
Finally, in order to assess whether a minor modiﬁcation
(i.e. addition of methyl groups) to the C2/C20-substituents
of DRG-16 (2) might inﬂuence its cross-linking properties,
a similar set of HPLC experiments was conducted with the
PBD dimer ELB-21 (3) in which it behaved in an identical
manner to 2. Figures 7A–F show the HPLC proﬁles for
reaction of 3 with the key six duplex sequences at the point
at which reaction had gone to completion, except in the
case of Figure 7C (Pu-GAAATC-Py) and E
(Pu-GATG-Py), the least preferred sequences, in which
reaction was incomplete after 24h. The identiﬁcation of
each peak was conﬁrmed using MALDI–TOF–MS data
(Supplementary Table S3, see Supplementary Data).
Molecular modelling studies
In an attempt to visualize and rationalize interaction of
the three PBD dimers with the different DNA sequences,
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Figure 7. HPLC chromatograms for ELB-21 (3); (A) 1h after mixing 3 with the Seq-4/Seq-5 duplex showing complete formation of the interstrand
3/(Seq-4/Seq-5) Pu-GAATC-Py adduct at RT 30.9min; (B) 3h after mixing 3 with the Seq-1/Seq-1 duplex showing complete formation of interstrand
3/(Seq-1/Seq-1) Pu-GATC-Py duplex adduct at RT 28.7min, along with a minor peak at RT 34.2; (C) 24h after mixing 3 with the Seq-12/Seq-13
duplex showing reaction nearing completion with a minor peak for the interstrand 3/(Seq-12/Seq-13) Pu-GAAATC-Py duplex adduct at RT 29.8min,
along with close major peaks for 3/(Seq-12) and 3/(Seq-13) single-stranded adducts at approximately RT 33.4min. (D) 2h after mixing 3 with the
Seq-6/Seq-7 duplex showing completion of reaction and formation of the intrastrand 3/(Seq-6/Seq-7) Pu-GAATG-Py adduct at RT 29.8min, along
with minor peaks at RT 34.2 and 36.3min; (E) 24h after mixing 3 with the Seq-2/Seq-3 duplex showing intrastrand 3/(Seq-2/Seq-3) Pu-GATG-Py
duplex adduct at RT 30.9min, along with additional peaks at RT 34.6 and 37.1min (reaction still not complete), (F) 3h after mixing 3 with the
Seq-14/Seq-15 duplex showing completion of reaction and formation of major peaks for the intrastrand Pu-GAAATG-Py duplex adduct at 29.8min
and minor single-stranded adducts at 33.6 and 34.1min.
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1, 2 and 3 within the various cross-linking sites while at-
tempting to estimate the proximity of the reacting guanines
to the two electrophilic N10-C11 imine moieties.
According to these models, both 1 and 2 appear to be
easily accommodated within their ideal sequences as deter-
mined by previous modelling studies (5,13) (i.e. two and
three AT base pairs between reacting guanines, respect-
ively), and also in those which are 1bp shorter. As previ-
ously reported for SJG-136 and the Pu-GATC-Py/Pu-
GATG-Pu sequence (13), model building shows that for
B-form DNA, the C2-NH2 of a guanine occupies an
almost identical mid-groove position whichever strand it
is located on, albeit with the -NH2 in an opposite orien-
tation. Thus, for DRG-16 (2), after covalently linking one
end of it to guanine-5 of either the 50-TATAGAATC
TATA-30 or 50-TATAGAATGTATA-30 duplexes, the
C2-NH2 of the other reacting guanine (whether on the
same or opposite strand) occupies an almost identical
mid-groove position, supporting the feasibility of
forming both inter- and intrastrand cross-links.
Molecular dynamics simulations were carried out for
both SJG-136 (1) and DRG-16 (2) with their extended
interstrand and intrastrand sequences (i.e. three and four
AT base pairs between reacting guanines, respectively),
and some distortion of the DNA became evident, neces-
sary to maintain the cross-link over the given span of
bases. The greater distortion observed in the extended
interstrand models over the course of the molecular
dynamics simulations is evident from the graphs of
RMS deviation of atom coordinates of 1 and 2 when co-
valently linked through the guanines (see Supplementary
Figures S24 and S25 of Supplementary Data). The initial
minimized models used for the simulations showed how,
in the case of the extended sequences, the C8/C80 linker is
forced to adopt a lower position in the minor groove.
Figure 8 shows superimposed models for DRG-16 (2) co-
valently bound to the three interstrand (Figure 8A) and
three intrastrand cross-linking sequences (Figure 8B)
of different length. For both 1 (see Supplementary
Figure S22 and Supplementary Data) and 2, the position
of the C8/C80-linker in the groove corresponds to whether
there are 1, 2 or 3 (for SJG-136) or 2, 3 or 4 (for DRG-16)
base pairs between reacting guanines, respectively, with
the lowest position adopted for the longest sequence.
Thus, in these models, the position of the linker with
Figure 8. Overlay of energy minimised molecular models of the different types of covalent cross-linked adducts formed by DRG-16 (2) with the
duplex oligonucleotides of different lengths and cross-linking potential (i.e. inter- versus intrastrand): (A) DRG-16 interstrand cross-linking with
Pu-GATC-Py (green ligand), Pu-GAATC-Py (blue ligand) and Pu-GAAATC-Py (red ligand) duplex oligonucleotides; (B) DRG-16 intrastrand
cross-linking with Pu-GATG-Py (green ligand), Pu-GAATG-Py (blue ligand) and Pu-GAAATG-Py (red ligand) duplex oligonucleotides. Note:
In both ﬁgures the covalently bound guanine bases are highlighted in purple.
Nucleic Acids Research, 2011,Vol.39, No. 13 5809respect to the minor-groove ﬂoor directly reﬂects the dif-
ferences in distance between the two electrophilic imine
moieties of the PBD dimer and the two nucleophilic
C2-NH2 groups of the reacting guanines. Analysis of the
van der Waals contacts between the linkers and DNA
atoms for the most extended sequences showed that the
contacts were close but not overlapping in this region.
Interestingly, for both molecules, more distortion was
observed for the interstrand compared to the intrastrand
adducts, consistent with the experimentally observed pref-
erence for the intrastrand forms. Furthermore, the degree
of distortion of the interstrand adduct was considerably
higher in the case of 2, consistent with the mono-adducts
formed in the reaction between 2 and its extended
interstrand sequence. The formation of mono-adducts
was not observed during the reaction of 1 with its corres-
ponding extended sequence.
To further support the preference of 1 and 2 to form
inter- or intrastrand cross-linked adducts depending on
the spatial separation of reactive guanines, molecular
dynamics simulations were carried out for each molecule
cross-linked to three pairs of inter- and intrastrand se-
quences (Table 3), and an average potential energy (PE)
was determined for each adduct. Except for the adducts of
2 with the ideal base separation (i.e. Seq-4/Seq-5 and
Seq-6/Seq-7), in each case the average PE values sup-
ported the experimentally observed results, with the
interstrand adducts having lower energies for the ideal
and shorter length sequences, while for the extended se-
quences the intrastrand adducts had a signiﬁcantly lower
average PE value. Although the PE values for adducts of 2
with Pu-GAATG-Py and Pu-GAATC-Py were the reverse
of that anticipated, they are only 3.34kcal/mol apart, and
the experimentally observed rates of formation of these
intrastrand and interstrand adducts are more similar (i.e.
 95% versus 85%, respectively, after 1h) compared to the
reaction of SJG-136 (1) with its equivalent Pu-GATG-Py
and Pu-GATC-Py sequences (i.e.  50% reaction after
12h and 5min, respectively) (12), consistent with the
greater difference of 8.07kcal/mol.
CONCLUSIONS
The data presented here demonstrate that preference for
the type of adduct formed (i.e. interstrand versus intra-
strand) between PBD dimers and DNA can be ratio-
nalized and predicted based on whether the guanines are
on the same or opposite strands of a DNA duplex, the
distance between the two reacting guanines, and the length
of the linker between the C8/C80-positions of the two PBD
units of the dimer.
For SJG-136 (1) which has a C8–O–(CH2)3–O–C80
linker, there is a preference for interstrand cross-linking
with Pu-GAC-Py or Pu-GATC-Py sequences rather
than cross-linking with the isomeric intrastrand sequences,
although reaction is much slower with the shorter
sequence. For the longer Pu-GAATC-Py or Pu-GAATC
-Py sequences, intrastrand cross-linking is preferred, and
is more rapid than the interstrand cross-linking that
occurs with the shorter sequences. Also, with these
longer sequences, monoalkylated adducts begin to
appear as minor products, which may represent intermedi-
ate species en-route to the ﬁnal cross-linked adducts.
Finally, with the even longer Pu-GAAATG-Py and
Pu-GAAATG-Py sequences, 1 cannot reach between the
two guanines when the bases are either on the same or
opposite strands, and so monoalkylated adducts are
observed almost exclusively.
For DRG-16 (2) and ELB-21 (3) which contain the
longer C8–O–(CH2)5–O–C80 linker, there is a preference
for interstrand cross-linking with Pu-GATC-Py or Pu-GA
ATC-Py sequences rather than cross-linking with the
isomeric intrastrand sequences, although reaction is
slower with the shorter sequence. However, for both 2
and 3, reaction with the intrastrand Pu-GAATG-Py
sequence was found to be very rapid compared to the
equivalent reaction of 1 with the intrastrand sequence
Pu-GATG-Py, perhaps reﬂecting the greater ﬂexibility of
the longer central C8/C80 linker. For the longer Pu-GAAA
TC-Py and Pu-GAAATG-Py sequences, intrastrand
cross-linking is preferred and is more rapid than the
interstrand cross-linking that occurs with shorter
Table 3. Average potential energies for a 2000ps molecular dynamics simulation of the different types of covalent cross-linked adducts formed
by SJG-136 (1) and DRG-16 (2) with duplex oligonucleotides containing one to four AT-base pairs between reacting guanines
DNA sequence of
duplex oligonucleotide
Type of
cross-link
possible
Average
potential energy
(kcal/mol)
of SJG-136
cross-linked
adducts
Average
potential energy
(kcal/mol) of
DRG-16
cross-linked
adducts
Type of cross-link
preferred by
SJG-136 observed
in HPLC studies
Type of cross-link
preferred by
DRG-16 observed
in HPLC studies
Pu-GAC-Py (Seq-13/Seq-14) Interstrand  3361.86 Sequence too
short to form
cross-links
Interstrand Sequence too
short to form
cross-links
Pu-GAG-Py (Seq-10/Seq-11) Intrastrand  3361.57
Pu-GATC-Py (Seq-1/Seq-1) Interstrand  3678.54  3680.54 Interstrand Interstrand
Pu-GATG-Py (Seq-2/Seq-3) Intrastrand  3670.47  3671.13
Pu-GAATC-Py (Seq-4/Seq-5) Interstrand  3955.65  3972.74 Intrastrand Interstrand
Pu-GAATG-Py (Seq-6/Seq-7) Intrastrand  3980.09  3976.08
Pu-GAAATC-Py (Seq-12/Seq-13) Interstrand Sequence too
long to form
cross-links
 4253.13 Sequence
too long to
form cross-links
Intrastrand
Pu-GAAATG-Py (Seq-14/Seq-15) Intrastrand  4264.31
5810 Nucleic Acids Research, 2011,Vol.39, No. 13sequences. For these longer sequences, monoalkylated
adducts begin to appear as minor products, which may
represent intermediate species en route to the ﬁnal
cross-linked adducts. Finally, for the even longer Pu-GA
AAATC-Py and Pu-and GAAAATG-Py sequences, these
PBD dimers cannot reach between the two guanines when
on the same or opposite strands, and so only
mono-adducts are observed.
Although only three PBD dimers were investigated in
this study, given that 2a nd 3 behaved in a similar fashion,
it is likely that preference for intrastrand or interstrand
cross-linking with particular DNA sequences may be
more dependent on the C8/C80 linker length than struc-
tural differences in the C-rings.
The various types of adducts formed by PBD dimers
may be relevant to the biological activity of this class of
antitumour agents. At present, the interstrand cross-links
produced by SJG-136 (1) at Pu-GATC-Py sequences are
thought to be responsible for its mechanism of action
(20,21), and these are measured in in vitro cell-based ex-
periments and in peripheral blood lymphocytes (PBLs)
during clinical trials using the COMET (22) and gamma
yH2AX-foci (23) assays. However, further studies are
now required to determine whether intrastrand or
monoalkylation adducts also contribute to the biological
activity.
Finally, these observations, and the simple rules that
appear to explain them, suggest that it may be possible
to design novel PBD dimers as chemical probes or thera-
peutic agents to produce predominantly one type of DNA
adduct in cells. Further studies are underway to try to
understand the effect of more signiﬁcant changes to the
C8/C80-linker (such as the insertion of heteroatoms) on
the pattern of adducts produced.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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